Okay, hereâ€™s an academic-style abstract based on the provided summary, incorporating precise terminology, structured reasoning, and reflecting a 2020 context, aiming for approximately 203 words:

**Abstract**

Diffuse gliomas represent a significant clinical challenge within neuro-oncology, demanding refined diagnostic and therapeutic strategies in adult patients.  Recent advancements in understanding glioma biology and treatment efficacy necessitate continuous updates to clinical guidelines. This study examines the implementation and impact of the updated European Association of Neuro-Oncology (EANO) guidelines, released in 2020, for the management of adult diffuse glioma patients. 

The EANO guidelines synthesize evolving evidence from recent clinical trials and reflect revisions to the World Health Organization (WHO) grading system.  Specifically, the revised recommendations emphasize a more nuanced approach to diagnosis, incorporating multimodal imaging techniques to facilitate accurate histological subtyping.  Furthermore, the guidelines detail evolving treatment algorithms, acknowledging the heterogeneity of diffuse gliomas and advocating for personalized therapeutic strategies, including surgical resection, radiation therapy, and targeted systemic therapies. 

Crucially, the document provides detailed protocols for long-term follow-up, emphasizing the importance of regular neuro-radiological assessments and monitoring for treatment response and recurrence.  Adherence to these updated guidelines offers a framework for improved patient outcomes and standardized care within the complex landscape of adult diffuse glioma management. Future research should focus on validating the efficacy of these recommendations across diverse patient populations and exploring novel therapeutic targets.